Valproate-induced biochemical abnormalities in pregnancy corrected by vitamins: A case report

Epilepsia

Volumn 40, Issue 4, 1999, Pages 512-515

  Baggot, Paddy Jim ^a   Kalamarides, Jeremy A ^a   Shoemaker, James D ^b  

^a Pope Paul VI Institute   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Pregnancy; Urinary metabolites; Valproate; Vitamins

Indexed keywords

VALPROIC ACID; VITAMIN;

ADULT; ARTICLE; BRAIN GROWTH; CASE REPORT; DIET SUPPLEMENTATION; DRUG EFFECT; EPILEPSY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; NERVOUS SYSTEM DEVELOPMENT; PREGNANCY; PRIORITY JOURNAL; TERATOGENESIS; TERATOGENICITY; URINARY EXCRETION;

EID: 0032940197     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1999.tb00750.x     Document Type: Article

References (14)

1. Jones KY. Smith's recognizable patterns of human malformation. 4th ed. Philadelphia: WB Saunders, 1988.
2. Jäger-Roman E, Deichl A, Jakob S, et al. Fetal growth, major malformations, and minor anomalies in inborn infants born to women receiving valproic acid. J Pediatr 1986;108:997-1004.
3. Ardinger HH, Atkin JF, Blackston RD, et al. Verification of the fetal valproate syndrome phenotype. Am J Med Genet 1988;29: 171-85.
4. Christianson AL, Chesler N, Kromherg JGR. Fetal valproate syndrome: clinical and neurodevelopmental features of two sibling pairs. Dev Med Child Neurol 1994;36:361-9.
5. Koch S. Jäger-Roman E, Lsche G, Nau H, Rating D, Helge H. Antiepileptic drug treatment in pregnancy: drug side effects in the neonate and neurological outcome. Acta Paediatr 1986;85:739-46.
6. Baillie TA, Sheffels PR. Valproic acid chemistry and biotransformation. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs. 4th ed. New York: Raven Press, 1995:589-604.
7. Sato M, Shirota M, Nagao T. Pantothenic acid decreases valproic acid-induced neural tube defects in mice (I). Teratology 1995;52: 143-8.
8. 6 on valproic acid-induced teratogenesis in mice. Fundam Appl Toxicol 1992;18:389-94.
9. Triggs WJ, Roe CR, Rhead WJ, Hanson SK, Lin SN, Willmore LJ. Neuropsychiatric manifestations of defect in mitochondrial beta-oxidation response to riboflavin. J Neurol Neurosurg Psychiatry 1992;55:209-11.
10. Gillman MA, Sandyk R. Nicotinic acid deficiency induced by sodium valproate. S Afr Med J 1984;65:986.
11. Thurston JH, Hauhart RE. Vitamins to prevent neural-tube defects. N Engl J Med 1993;328:1641-2.
12. Dreifuss F. Ethosuximide toxicity. In: Levy RH. Mattson RH. Meldrum BS. eds. Antiepileptic drugs. 4th ed. New York: Raven Press. 1995:675-9.
13. Shoemaker JD, Elliott WH. Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease. J Chromatogr 1991;562:125-38.
14. Milne MD, Scribner H, Crawford MA. Non-ionic diffusion and the excretion of weak acids and bases. Am J Med 1958;24:709-19.